Basics Recursion Pharmaceuticals, Inc. IPO Date: April 16, 2021 Sector: Healthcare Industry: Biotech Market Cap: $2.45B Activated in VL: True Average Daily Range Avg Daily Range: $0.42 | 3.90% Avg Daily Range (30 D): $0.16 | 3.35% Avg Daily Range (90 D): $0.18 | 3.47% Institutional Daily Volume Avg Daily Volume: 7.92M Avg Daily Volume (30 D): 29.9M Avg Daily Volume (90 D): 33.81M Trade Size Avg Trade Size (Sh.): 231 Avg Trade Size (Sh.) (30 D): 413 Avg Trade Size (Sh.) (90 D): 424 Institutional Trades Total Inst.Trades: 2,565 Avg Inst. Trade: $2.25M Avg Inst. Trade (30 D): $1.89M Avg Inst. Trade (90 D): $2.12M Avg Inst. Trade Volume: .29M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.88M Avg Closing Trade (30 D): $4.23M Avg Closing Trade (90 D): $4.98M Avg Closing Volume: 491.41K     News Nov 19, 2025 @ 1:13 PM Is Recursion Pharmaceuticals a Meme Stock? Source: Prosper Junior Bakiny Oct 31, 2025 @ 10:15 AM Could Recursion Pharmaceuticals Be the Next Big Ar... Source: David Jagielski Oct 20, 2025 @ 4:07 PM Recursion Pharmaceuticals (RXRX) CEO Sells 100,000... Source: Cory Renauer Oct 16, 2025 @ 1:31 PM Is Recursion Pharmaceuticals a Millionaire Maker? Source: Keith Speights Oct 14, 2025 @ 3:41 PM Absci Stock Offers High-Risk AI Biotech Exposure W... Source: Nathan Reiff Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.36 $-.41 $-.5 Diluted EPS $-.36 $-.41 $-.5 Revenue $ 5.18M $ 19.22M $ 14.75M Gross Profit $ -9.51M $ -.94M $ -7.08M Net Income / Loss $ -162.25M $ -171.9M $ -202.49M Operating Income / Loss $ -172.2M $ -176.23M $ -191.37M Cost of Revenue $ 14.69M $ 20.16M $ 21.83M Net Cash Flow $ 133.3M $ 24.69M $ -93.87M PE Ratio